The Barbadian government is moving to significantly reform its drug regulatory system by tabling new legislation in the Senate. This proposed bill aims to establish a new authority dedicated to overseeing medical products within the country.
The creation of this new body is intended to strengthen regulatory oversight and improve public access to essential medicines. It also seeks to streamline the regulatory processes governing medical products, enhancing efficiency and safety.
These reforms underscore the government’s commitment to ensuring the safety, efficacy, and availability of pharmaceutical and medical supplies for its citizens. The legislation represents a comprehensive approach to modernizing national drug control and health standards.
Source: Barbados Today | Published: Wed, 10 Jun 2026 22:30:15 GMT
Leave a Reply